Ocular manifestations of rheumatic disorders. Natural and iatrogenic.
D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D001167:Arteritis / Q000150:complications; D001171:Arthritis, Juvenile / Q000150:complications; D001172:Arthritis, Rheumatoid / Q000150:complications; D002738:Chloroquine / Q000009:adverse effects; D003231:Conjunctivitis / Q000209:etiology; D003882:Dermatomyositis / Q000150:complications; D005128:Eye Diseases / Q000139:chemically induced*; D005132:Eye Manifestations; D005901:Glaucoma / Q000139:chemically induced; D006046:Gold / Q000009:adverse effects; D014890:Granulomatosis with Polyangiitis / Q000150:complications; D006801:Humans; D006886:Hydroxychloroquine / Q000009:adverse effects; D007049:Iatrogenic Disease; D007213:Indomethacin / Q000009:adverse effects; D007634:Keratitis / Q000209:etiology; D008180:Lupus Erythematosus, Systemic / Q000150:complications; D010488:Polyarteritis Nodosa / Q000150:complications; D011111:Polymyalgia Rheumatica / Q000150:complications; D012164:Retinal Diseases / Q000209:etiology; D012216:Rheumatic Diseases / Q000150:complications*; D012590:Sclera; D012595:Scleroderma, Systemic / Q000150:complications; D012859:Sjogren's Syndrome / Q000150:complications; D013167:Spondylitis, Ankylosing / Q000150:complications; D014605:Uveitis / Q000209:etiology
D000305:Adrenal Cortex Hormones; D006886:Hydroxychloroquine; D006046:Gold; D002738:Chloroquine; D007213:Indomethacin